Replimune's innovative cancer therapies, strong cash reserves, and FDA support position it to disrupt oncology markets. Click ...

The new therapy is known as oncolytic virus therapy, that uses a virus to destroy cancer cells but leaves healthy cells untouched. The FDA has approved one of these therapies to date, called T-VEC ...

Oncolytic virus therapy is not a new discovery, but it may now be positioned as the next major breakthrough in cancer treatment following the success of checkpoint inhibitors in immunotherapy.

Explore the latest insights into global clinical trial trends, innovations, and strategies shaping the future of oncolytic virus therapy. Oncolytic virus therapies utilize genetically modified or ...

An oncolytic virus kills a cancer cell by replicating ... Some cancers are sensitive to the levels of specific hormones. Hormone therapy uses medication to lower or block their production, which ...

Oncolytic immunotherapy is a cancer treatment that exploits the ability of certain viruses to selectively replicate in an direct kill turmors, as well as induce a potent, patient-specific ...

New research highlights the potential of the novel diagnostic tool iFRET to determine immunotherapy outcomes in stage 2 ...

Intravenous; NDV: Newcastle disease virus; OS: Overall survival ... Other proteins such as H-Ras and Rac1 have been shown to mediate oncolytic specificity in certain systems.

Oncolytic Virus Therapy: Global Clinical Trial Landscape 2024. This comprehensive whitepaper analyzes the evolving landscape of oncolytic virus therapies (OVT), providing critical insights into ...